Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System

Zuzana Skubalova,1,2 Simona Rex,1,2 Martina Sukupova,1 Martin Zahalka,1 Petr Skladal,3 Jan Pribyl,3 Hana Michalkova,1,2 Akila Weerasekera,4 Vojtech Adam,1,2 Zbynek Heger1,2 1Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic; 2Central European Institute of Tech...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Skubalova Z, Rex S, Sukupova M, Zahalka M, Skladal P, Pribyl J, Michalkova H, Weerasekera A, Adam V, Heger Z
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
Acceso en línea:https://doaj.org/article/9696b6f0dd2846acb00866412d6aad4f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9696b6f0dd2846acb00866412d6aad4f
record_format dspace
spelling oai:doaj.org-article:9696b6f0dd2846acb00866412d6aad4f2021-12-02T16:01:14ZPassive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System1178-2013https://doaj.org/article/9696b6f0dd2846acb00866412d6aad4f2021-01-01T00:00:00Zhttps://www.dovepress.com/passive-diffusion-vs-active-ph-dependent-encapsulation-of-tyrosine-kin-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Zuzana Skubalova,1,2 Simona Rex,1,2 Martina Sukupova,1 Martin Zahalka,1 Petr Skladal,3 Jan Pribyl,3 Hana Michalkova,1,2 Akila Weerasekera,4 Vojtech Adam,1,2 Zbynek Heger1,2 1Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic; 2Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic; 3Central European Institute of Technology, Masaryk University, Brno, Czech Republic; 4Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USACorrespondence: Zbynek HegerDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech RepublicTel +420-5-4513-3350Fax +420-5-4521-2044Email heger@mendelu.czIntroduction: The present study reports on examination of the effects of encapsulating the tyrosine kinase inhibitors (TKIs) vandetanib and lenvatinib into a biomacromolecular ferritin-based delivery system.Methods: The encapsulation of TKIs was performed via two strategies: i) using an active reversible pH-dependent reassembly of ferritin´s quaternary structure and ii) passive loading of hydrophobic TKIs through the hydrophobic channels at the junctions of ferritin subunits. After encapsulation, ferritins were surface-functionalized with folic acid promoting active-targeting capabilities.Results: The physico-chemical and nanomechanical analyses revealed that despite the comparable encapsulation efficiencies of both protocols, the active loading affects stability and rigidity of ferritins, plausibly due to their imperfect reassembly. Biological experiments with hormone-responsive breast cancer cells (T47-D and MCF-7) confirmed the cytotoxicity of encapsulated and folate-targeted TKIs to folate-receptor positive cancer cells, but only limited cytotoxic effects to healthy breast epithelium. Importantly, the long-term cytotoxic experiments revealed that compared to the pH-dependent encapsulation, the passively-loaded TKIs exert markedly higher anticancer activity, most likely due to undesired influence of harsh acidic environment used for the pH-dependent encapsulation on the TKIs’ structural and functional properties.Conclusion: Since the passive loading does not require a reassembly step for which acids are needed, the presented investigation serves as a solid basis for future studies focused on encapsulation of small hydrophobic molecules.Keywords: drug delivery, nanomedicine, lenvatinib, vandetanibSkubalova ZRex SSukupova MZahalka MSkladal PPribyl JMichalkova HWeerasekera AAdam VHeger ZDove Medical Pressarticledrug deliverynanomedicinelenvatinibvandetanibMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 16, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic drug delivery
nanomedicine
lenvatinib
vandetanib
Medicine (General)
R5-920
spellingShingle drug delivery
nanomedicine
lenvatinib
vandetanib
Medicine (General)
R5-920
Skubalova Z
Rex S
Sukupova M
Zahalka M
Skladal P
Pribyl J
Michalkova H
Weerasekera A
Adam V
Heger Z
Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
description Zuzana Skubalova,1,2 Simona Rex,1,2 Martina Sukupova,1 Martin Zahalka,1 Petr Skladal,3 Jan Pribyl,3 Hana Michalkova,1,2 Akila Weerasekera,4 Vojtech Adam,1,2 Zbynek Heger1,2 1Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, Czech Republic; 2Central European Institute of Technology, Brno University of Technology, Brno, Czech Republic; 3Central European Institute of Technology, Masaryk University, Brno, Czech Republic; 4Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA, USACorrespondence: Zbynek HegerDepartment of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, Brno CZ-613 00, Czech RepublicTel +420-5-4513-3350Fax +420-5-4521-2044Email heger@mendelu.czIntroduction: The present study reports on examination of the effects of encapsulating the tyrosine kinase inhibitors (TKIs) vandetanib and lenvatinib into a biomacromolecular ferritin-based delivery system.Methods: The encapsulation of TKIs was performed via two strategies: i) using an active reversible pH-dependent reassembly of ferritin´s quaternary structure and ii) passive loading of hydrophobic TKIs through the hydrophobic channels at the junctions of ferritin subunits. After encapsulation, ferritins were surface-functionalized with folic acid promoting active-targeting capabilities.Results: The physico-chemical and nanomechanical analyses revealed that despite the comparable encapsulation efficiencies of both protocols, the active loading affects stability and rigidity of ferritins, plausibly due to their imperfect reassembly. Biological experiments with hormone-responsive breast cancer cells (T47-D and MCF-7) confirmed the cytotoxicity of encapsulated and folate-targeted TKIs to folate-receptor positive cancer cells, but only limited cytotoxic effects to healthy breast epithelium. Importantly, the long-term cytotoxic experiments revealed that compared to the pH-dependent encapsulation, the passively-loaded TKIs exert markedly higher anticancer activity, most likely due to undesired influence of harsh acidic environment used for the pH-dependent encapsulation on the TKIs’ structural and functional properties.Conclusion: Since the passive loading does not require a reassembly step for which acids are needed, the presented investigation serves as a solid basis for future studies focused on encapsulation of small hydrophobic molecules.Keywords: drug delivery, nanomedicine, lenvatinib, vandetanib
format article
author Skubalova Z
Rex S
Sukupova M
Zahalka M
Skladal P
Pribyl J
Michalkova H
Weerasekera A
Adam V
Heger Z
author_facet Skubalova Z
Rex S
Sukupova M
Zahalka M
Skladal P
Pribyl J
Michalkova H
Weerasekera A
Adam V
Heger Z
author_sort Skubalova Z
title Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
title_short Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
title_full Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
title_fullStr Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
title_full_unstemmed Passive Diffusion vs Active pH-Dependent Encapsulation of Tyrosine Kinase Inhibitors Vandetanib and Lenvatinib into Folate-Targeted Ferritin Delivery System
title_sort passive diffusion vs active ph-dependent encapsulation of tyrosine kinase inhibitors vandetanib and lenvatinib into folate-targeted ferritin delivery system
publisher Dove Medical Press
publishDate 2021
url https://doaj.org/article/9696b6f0dd2846acb00866412d6aad4f
work_keys_str_mv AT skubalovaz passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT rexs passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT sukupovam passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT zahalkam passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT skladalp passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT pribylj passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT michalkovah passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT weerasekeraa passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT adamv passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
AT hegerz passivediffusionvsactivephdependentencapsulationoftyrosinekinaseinhibitorsvandetanibandlenvatinibintofolatetargetedferritindeliverysystem
_version_ 1718385287854292992